pilocarpine has been researched along with salmeterol xinafoate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Johansson, I; Ryberg, M | 1 |
2 other study(ies) available for pilocarpine and salmeterol xinafoate
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
The effects of long-term treatment with salmeterol and salbutamol on the flow rate and composition of whole saliva in the rat.
Topics: Adrenergic beta-Agonists; Albuterol; Amylases; Analysis of Variance; Animals; Calcium; Electrolytes; Hexosamines; Isoproterenol; Male; N-Acetylneuraminic Acid; Organ Size; Parotid Gland; Pilocarpine; Rats; Rats, Sprague-Dawley; Saliva; Salivary Glands; Salivary Proteins and Peptides; Salivation; Salmeterol Xinafoate; Secretory Rate; Sialic Acids; Statistics, Nonparametric; Stimulation, Chemical; Submandibular Gland | 1995 |